Brief: ALX Oncology Q2 Basic EPS USD -0.84
10/08/2023 21:01
Aug 10 (Reuters) - ALX Oncology Q2 income from operations USD -36.777 million. * Q2 net income USD -34.159 million * Q2 operating expenses USD 36.777 million
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing